<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Short-lasting unilateral neuralgiform headache attacks: Clinical features and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Short-lasting unilateral neuralgiform headache attacks: Clinical features and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Short-lasting unilateral neuralgiform headache attacks: Clinical features and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Manjit S Matharu, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anna S Cohen, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jerry W Swanson, MD, MHPE
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard P Goddeau, Jr, DO, FAHA
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 28, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION AND CLASSIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The trigeminal autonomic cephalalgias (TACs) are a group of primary headache disorders characterized by unilateral trigeminal distribution pain that occurs in association with ipsilateral cranial autonomic features [
         <a href="#rid1">
          1,2
         </a>
         ]. The TACs include cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks, and hemicrania continua [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         There are two subtypes of short-lasting unilateral neuralgiform headache attacks [
         <a href="#rid3">
          3,4
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)
        </p>
        <p>
        </p>
        <p>
         The clinical features and diagnosis of SUNCT and SUNA will be reviewed here. The management of these syndromes are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3338.html" rel="external">
          "Short-lasting unilateral neuralgiform headache attacks: Treatment and prognosis"
         </a>
         .)
        </p>
        <p>
         Other TACs are discussed elsewhere.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3326.html" rel="external">
          "Cluster headache: Epidemiology, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3351.html" rel="external">
          "Cluster headache: Treatment and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3334.html" rel="external">
          "Paroxysmal hemicrania: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3335.html" rel="external">
          "Paroxysmal hemicrania: Treatment and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3342.html" rel="external">
          "Hemicrania continua"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          HISTORICAL ASPECTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         SUNCT is a rare primary headache syndrome first reported in 1978 [
         <a href="#rid5">
          5
         </a>
         ] and later described more fully [
         <a href="#rid6">
          6,7
         </a>
         ]. In 2004, SUNCT syndrome was included in the International Classification of Headache Disorders, 2
         <sup>
          nd
         </sup>
         edition [
         <a href="#rid8">
          8
         </a>
         ], as was the related syndrome SUNA. In 2013, both SUNCT and SUNA were classified as subtypes of short-lasting unilateral neuralgiform headache attacks (
         <a class="graphic graphic_table graphicRef74387" href="/z/d/graphic/74387.html" rel="external">
          table 1
         </a>
         ) by the International Classification of Headache Disorders, 3
         <sup>
          rd
         </sup>
         edition beta [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both SUNCT and SUNA are rare headache syndromes, but the prevalence and incidence are uncertain. A study from Australia reported an estimated annual incidence of 1.2 per 100,000 and prevalence of 6.6 per 100,000 [
         <a href="#rid9">
          9
         </a>
         ]. By contrast, an epidemiologic study from Norway found two subjects with SUNCT-like syndromes among a group of 1838 subjects, corresponding to a prevalence of 109 per 100,000 [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         The typical age of onset is between 30 and 60 years but may range from 5 to 88 years [
         <a href="#rid11">
          11-13
         </a>
         ]. The largest case series found the mean age of onset for SUNCT and SUNA was approximately 44 years [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         SUNCT and SUNA have a female predominance [
         <a href="#rid13">
          13
         </a>
         ]. The female-to-male ratio is 1.7:1, with the female preponderance being more pronounced in patients with SUNA (2.4:1) compared with those with SUNCT (1.2:1) [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         There is one reported kindred of a family history of SUNCT [
         <a href="#rid14">
          14
         </a>
         ]. However, SUNCT and SUNA are so rare that an accurate evaluation of their genetic status is difficult.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          CLINICAL FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         SUNCT and SUNA are characterized by sudden brief attacks of severe unilateral head pain in any of the three divisions of the trigeminal nerve accompanied by ipsilateral cranial autonomic symptoms [
         <a href="#rid13">
          13,15
         </a>
         ].
        </p>
        <p>
         For patients with SUNCT, the ipsilateral autonomic symptoms consist of both conjunctival injection and lacrimation. For those with SUNA, the autonomic symptoms may include either conjunctival injection or lacrimation but not both. Otherwise, the presence of cranial autonomic symptoms for SUNCT and SUNA is similar and may include nasal congestion, rhinorrhea, miosis, ptosis, eyelid edema, or forehead and facial sweating and/or flushing [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Site of pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pain in SUNCT and SUNA is unilateral and commonly located in ophthalmic (V1) and maxillary (V2) divisions of the trigeminal nerve; however, up to one-third of patients also have involvement in the mandibular (V3) division [
         <a href="#rid13">
          13
         </a>
         ]. On rare occasions, the pain can radiate to the occiput, neck, or ear [
         <a href="#rid13">
          13,15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Temporal profile of individual attacks
         </span>
         <span class="headingEndMark">
          —
         </span>
         The International Classification of Headache Disorders, 3
         <sup>
          rd
         </sup>
         edition criteria for short-lasting unilateral neuralgiform headache attacks specify an attack length of 1 to 600 seconds, with an attack frequency of at least once a day for more than half the time when the disorder is active [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H547573870">
         <span class="h3">
          Patterns of attack recurrence
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a series of 43 patients with SUNCT and 9 with SUNA, attacks were categorized into one or more of four forms (
         <a class="graphic graphic_figure graphicRef74409" href="/z/d/graphic/74409.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid15">
          15
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Single stabs of pain with a median duration of 58 seconds (interquartile range [IQR] 10 to 120 seconds)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Repetitive stabs of pain with a median attack duration of 180 seconds (IQR 60 to 300 seconds)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         "Saw-tooth" attacks of continuous pain with multiple superimposed stabs (serrated attacks) with a median attack duration of 240 seconds (IQR 60 to 420 seconds)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Plateau-type attacks with a median duration of 300 seconds (IQR 20 to 600 seconds)
        </p>
        <p>
        </p>
        <p>
         Almost half of patients have more than one of these different forms of attacks [
         <a href="#rid13">
          13
         </a>
         ], and there is wide interpatient variation in both the length of attacks and number of attacks per day [
         <a href="#rid15">
          15
         </a>
         ]. SUNCT patients appear more likely to experience single stabs, and SUNA patients more likely to experience repetitive stabs. The saw-tooth and plateau patterns may occur with similar frequency in both SUNCT and SUNA [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1164281721">
         <span class="h3">
          Lack of refractory period between attacks
         </span>
         <span class="headingEndMark">
          —
         </span>
         SUNCT and SUNA symptoms generally do not have a refractory period [
         <a href="#rid6">
          6,13,15,18
         </a>
         ]. In a review with data available for 93 patients with SUNCT and SUNA, there was no refractory period in 90 percent [
         <a href="#rid16">
          16
         </a>
         ]. In the largest series, spontaneous or triggered attacks could occur immediately after cessation of the previous attack in 84 percent of SUNCT and 79 percent of SUNA [
         <a href="#rid13">
          13
         </a>
         ]. Only 7 percent of patients had a refractory period, typically lasting between 2 and 10 minutes.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Periodicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         In some cases, SUNCT or SUNA is an episodic disorder, with bouts of attacks alternating with remissions. In a report of 21 patients with SUNCT, symptomatic bouts typically occurred once or twice a year and lasted from days to months, with remissions lasting months at a time [
         <a href="#rid6">
          6
         </a>
         ]. Results from another series of 24 patients with SUNCT or SUNA suggested that the episodic form (attacks lasting seven days to one year, separated by a pain-free period lasting one month or longer) was more common than the chronic form (14 versus 10 subjects) [
         <a href="#rid9">
          9
         </a>
         ]. However, the time since diagnosis was relatively short for most of the patients in this series, and the natural progression of these syndromes points to a tendency to become chronic.
        </p>
        <p>
         By contrast, a large series of 133 patients with longer follow-up reported chronic symptoms was noted in 62 of 70 patients (89 percent) with SUNCT and 58 of 63 patients (92 percent) patients with SUNA [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Interictal pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Background pain between attacks is present in some patients with SUNCT and SUNA. In one series, persistent background pain was present in 53 percent of patients with SUNCT and 43 percent of those with SUNA [
         <a href="#rid13">
          13
         </a>
         ]. While one series reported that a history of migraine was associated with an interictal headache [
         <a href="#rid17">
          17
         </a>
         ], a larger prospective series did not confirm this finding [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Triggers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple triggers have been associated with short-lasting unilateral neuralgiform headache attacks [
         <a href="#rid6">
          6,13,19
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Touching the face or scalp
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bathing or showering
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Washing or brushing hair
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Shaving
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nose blowing
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chewing or eating
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Brushing teeth
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Talking
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Valsalva maneuvers
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exercise
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bright light (including sunlight and fluorescent lights)
        </p>
        <p>
        </p>
        <p>
         Neck movement may precipitate attacks in some patients or abort attacks in others [
         <a href="#rid6">
          6,7,20
         </a>
         ]. Some triggers characteristically associated with cluster headache, such as alcohol, smoke, strong smells, or a warm environment, may also trigger SUNCT or SUNA [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
         Most patients have either a mixture of spontaneous and triggered attacks or purely spontaneous attacks, but purely triggered attacks are rare, occurring in only 4 percent [
         <a href="#rid13">
          13
         </a>
         ]. A potential explanation is that some cases of purely triggered attacks may be incorrectly diagnosed with trigeminal neuralgia. Thus, it is useful to recognize that occasional patients with SUNCT may experience only triggered attacks.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Neurologic examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         The neurologic examination is usually normal in patients with short-lasting unilateral neuralgiform headache attacks, although ipsilateral trigeminal sensory findings are present in occasional patients. In our series, abnormal sensation to pinprick (mainly hypesthesia) in trigeminal V1 or V2 distribution was present in 6 of 43 patients (14 percent) with SUNCT and 2 of 9 with SUNA [
         <a href="#rid15">
          15
         </a>
         ]. Others have reported allodynia or hyperesthesia in the face [
         <a href="#rid6">
          6,22-24
         </a>
         ], a sensory deficit of the ophthalmic (V1) division of the trigeminal nerve [
         <a href="#rid25">
          25
         </a>
         ], and a persistent ipsilateral Horner syndrome [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of SUNCT or SUNA is based upon a compatible clinical history, typically in the setting of a normal neurologic examination. The diagnosis is supported by a
         <strong>
          lack
         </strong>
         of response to
         <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">
          indomethacin
         </a>
         and oxygen.
        </p>
        <p>
         Brain magnetic resonance imaging (MRI) is suggested for all patients being evaluated for SUNCT and SUNA. (See
         <a class="local">
          'Neuroimaging'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Diagnostic criteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of short-lasting unilateral neuralgiform headache attacks, according to the International Classification of Headache Disorders 3rd edition (ICHD-3), requires fulfilling all of the following criteria (
         <a class="graphic graphic_table graphicRef74387" href="/z/d/graphic/74387.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid3">
          3
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         At least 20 attacks
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Attacks consist of moderate or severe unilateral head pain, with orbital, supra-orbital, temporal and/or other trigeminal distribution, lasting for 1 to 600 seconds and occurring as single stabs, a series of stabs, or in a saw-tooth pattern
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         At least one of the following cranial autonomic symptoms or signs occurs ipsilateral to the pain:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Conjunctival injection and/or lacrimation
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nasal congestion and/or rhinorrhea
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Eyelid edema
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Forehead and facial sweating
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Miosis and/or ptosis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Attacks have a frequency of at least one a day for more than half of the time when the disorder is active
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Not better accounted for by another ICHD-3 diagnosis
        </p>
        <p>
        </p>
        <p>
         SUNCT is diagnosed if both conjunctival injection and lacrimation (tearing) occur ipsilateral to the pain [
         <a href="#rid3">
          3
         </a>
         ]. SUNA is diagnosed if only one or neither of conjunctival injection and lacrimation occurs. SUNCT syndrome may be a subform of SUNA. A comparative study of SUNCT and SUNA found no major clinical differences between these subtypes [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         Both SUNCT and SUNA can occur as episodic or chronic conditions [
         <a href="#rid3">
          3
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Episodic forms are characterized by at least two bouts of attacks occurring in periods lasting from seven days to one year (when untreated), separated by pain-free periods lasting three months or more
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic forms are characterized by attacks occurring for more than one year without remission, or with remission periods lasting less than three months
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Distinguishing features
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ascertaining the length and type of attacks is necessary to distinguish SUNCT and SUNA from other trigeminal autonomic cephalalgias, and thus obtaining a good history is paramount. This point is particularly important when the episodes consist of a series of saw-tooth pattern attacks or groups of stabs that have a longer duration [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="local">
          'Temporal profile of individual attacks'
         </a>
         above and
         <a class="local">
          'Diagnostic criteria'
         </a>
         above.)
        </p>
        <p>
         The presence of a cutaneous trigger and the lack of a refractory period between attacks, as well as the prominence of cranial autonomic symptoms, distinguish SUNCT from trigeminal neuralgia. In addition, cutaneous (or other) triggering of attacks and the lack of a response to
         <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">
          indomethacin
         </a>
         distinguish SUNCT from paroxysmal hemicrania and from hemicrania continua, which are both indomethacin-responsive.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Neuroimaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neuroimaging is useful to exclude SUNCT or SUNA caused by pituitary, posterior fossa, or focal lesions.
        </p>
        <p>
         For the initial evaluation of SUNCT/SUNA symptoms, we suggest brain MRI for patients with either a normal or abnormal neurologic exam because of the possibility of underlying or alternative diagnoses. Imaging should include sequences to assess the posterior fossa and pituitary structures. (See
         <a class="local">
          'Secondary headache'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6632.html" rel="external">
          "Causes, presentation, and evaluation of sellar masses"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Response to treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of SUNCT and SUNA is supported by a
         <strong>
          lack
         </strong>
         of response to
         <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">
          indomethacin
         </a>
         or oxygen, and by a
         <strong>
          good
         </strong>
         response to intravenous
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         .
        </p>
        <p>
         To exclude other trigeminal autonomic cephalalgia headache syndromes and aid in the diagnosis of SUNCT and SUNA, we suggest trials of
         <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">
          indomethacin
         </a>
         and oxygen [
         <a href="#rid27">
          27
         </a>
         ]. In a cohort of 10 patients with SUNCT and four with SUNA, the response to intramuscular indomethacin was no different than the response to
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         placebo in all patients (ie, the test was negative, ruling out paroxysmal hemicrania and hemicrania continua), and oxygen was ineffective in all (ie, suggesting that the diagnosis was not cluster headache) [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indomethacin
         </strong>
         – A blinded parenteral
         <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">
          indomethacin
         </a>
         test (the modified indotest) is useful to rule out paroxysmal hemicrania and hemicrania continua [
         <a href="#rid28">
          28,29
         </a>
         ]. This test is performed in two consecutive sessions with patients at baseline pain. In one session, indomethacin 100 mg is given by intramuscular injection. In the other session,
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         placebo is given by intramuscular injection. A positive test requires a significant reduction in attacks after indomethacin but not after placebo. However, intramuscular indomethacin is not available in some countries, including the United States.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A trial of oral
         <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">
          indomethacin
         </a>
         can be used to rule out paroxysmal hemicrania and hemicrania continua when parenteral indomethacin is not available. Although there are variations in recommended titration schedules and dosages, we suggest a nine-day trial of oral indomethacin. During the nine-day trial, patients increase the indomethacin dose every three days (up to a maximum total daily dose of 225 mg) unless they have resolution of headache, in which case they continue at the effective dose. The starting dose is indomethacin 75 mg to 100 mg daily (given in three divided doses) for three days; the dose can then be increased if necessary to a total daily dose of 150 mg for three days, followed if necessary by a total daily dose of 200 mg to 225 mg daily (given in at least three divided doses per day) for three days. Completion of the test without headache resolution is considered a failed trial. (See
         <a class="medical medical_review" href="/z/d/html/3334.html" rel="external">
          "Paroxysmal hemicrania: Clinical features and diagnosis", section on 'Indomethacin trial'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3342.html" rel="external">
          "Hemicrania continua", section on 'Diagnostic indomethacin trial'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Oxygen
         </strong>
         – The response to inhaled oxygen is helpful to exclude the diagnosis of cluster headache [
         <a href="#rid30">
          30
         </a>
         ]. Pure (100 percent) oxygen is applied via a nonrebreathing facemask with a flow rate of at least 7 L/min (sometimes more than 10 L/min) for 15 minutes at the start of an attack with the patient sitting in an upright position. Oxygen is generally safe and without side effects. However, patients with severe chronic obstructive pulmonary disease should not be treated with inhaled oxygen because of the risk for developing severe hypercapnia and carbon dioxide (CO
         <sub>
          2
         </sub>
         ) narcosis. Oxygen is effective for up to 78 percent of patients with cluster headache. (See
         <a class="medical medical_review" href="/z/d/html/3351.html" rel="external">
          "Cluster headache: Treatment and prognosis", section on 'Oxygen'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Patients with acute symptoms due to SUNCT or SUNA typically respond to intravenous
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         . Infusions of intravenous lidocaine are performed in the hospital with continuous electrocardiogram monitoring and may be contraindicated in some patients, including those with cardiac conduction system abnormalities. The use of lidocaine for acute treatment of SUNCT and SUNA is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3338.html" rel="external">
          "Short-lasting unilateral neuralgiform headache attacks: Treatment and prognosis", section on 'Lidocaine'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis for SUNCT and SUNA includes the following conditions:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other trigeminal autonomic cephalalgias (ie, cluster headache, paroxysmal hemicrania, and hemicrania continua)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Trigeminal neuralgia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Secondary causes of SUNCT and SUNA, particularly a posterior fossa lesion
        </p>
        <p>
        </p>
        <p>
         For cases where attacks appear to be prolonged, the main alternative diagnostic considerations are paroxysmal hemicrania and cluster headache. In cases of constant interictal pain, the main alternative diagnostic consideration is hemicrania continua. (See
         <a class="medical medical_review" href="/z/d/html/3334.html" rel="external">
          "Paroxysmal hemicrania: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3326.html" rel="external">
          "Cluster headache: Epidemiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Trigeminal neuralgia
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of SUNCT can be confused with trigeminal neuralgia [
         <a href="#rid3">
          3
         </a>
         ]. Similar to SUNCT and SUNA, trigeminal neuralgia can be precipitated by trivial stimuli such as washing, shaving, smoking, talking, and brushing the teeth, although attacks can sometimes occur spontaneously. Neurovascular contact occurs in more than half of patients with both conditions [
         <a href="#rid31">
          31-33
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5283.html" rel="external">
          "Trigeminal neuralgia"
         </a>
         .)
        </p>
        <p>
         Features that may be helpful to distinguish between trigeminal neuralgia and SUNCT or SUNA include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pattern of cranial autonomic features
         </strong>
         – The degree of cranial autonomic features (eg, conjunctival injection and tearing) within the ophthalmic division of trigeminal nerve is generally greater in patients with SUNCT than those with trigeminal neuralgia [
         <a href="#rid15">
          15,34,35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Interval between attacks
         </strong>
         – The bouts of pain in trigeminal neuralgia typically remit for variable intervals, whereas interictal intervals are likelier to be regular in SUNCT and SUNA.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Refractory period
         </strong>
         – Patients with trigeminal neuralgia typically report a refractory period after cessation of a bout of pain. SUNCT and SUNA symptoms generally do not have a refractory period [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         However, some authors have suggested they should be classified as a cranial neuralgia rather than a trigeminal autonomic cephalalgia due to similarities with trigeminal neuralgia [
         <a href="#rid36">
          36
         </a>
         ]. SUNCT and SUNA are likely to form part of a continuum with trigeminal neuralgia [
         <a href="#rid31">
          31,36,37
         </a>
         ], although these syndromes are still classified independently.
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Secondary headache
         </span>
         <span class="headingEndMark">
          —
         </span>
         SUNCT and SUNA are usually a primary headache disorder. However, there are a number of cases that are potentially secondary to intracranial lesions, typically located either in the posterior fossa or in the pituitary gland, as described below. In addition, there are case reports of SUNCT following viral meningitis or meningoencephalitis [
         <a href="#rid38">
          38,39
         </a>
         ] and traumatic head injury [
         <a href="#rid25">
          25,40
         </a>
         ].
        </p>
        <p>
         There is also a report of SUNCT secondary to an infraorbital metastatic bronchial carcinoid [
         <a href="#rid41">
          41
         </a>
         ]. Although not in the posterior fossa, this report would meet proposed criteria to identify causal links in secondary SUNCT [
         <a href="#rid42">
          42
         </a>
         ]. These criteria are the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A close temporal relationship between the associated disease and the onset of pain
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Side concordance between the unilateral pain and the lesion, if localized
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prompt remission after etiologic medical therapy, or remission after surgery; sufficient post-treatment follow-up is needed to exclude recurrence of the headache attacks or improvement due to spontaneous remission
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h3">
          Posterior fossa lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reports of SUNCT or SUNA associated with a posterior fossa abnormality include the following cases:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ipsilateral cerebellopontine arteriovenous malformation [
         <a href="#rid43">
          43,44
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Brainstem cavernous hemangioma [
         <a href="#rid45">
          45
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Posterior fossa lesion associated with HIV/AIDS [
         <a href="#rid1">
          1
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe basilar impression causing pontomedullary compression in a patient with osteogenesis imperfecta [
         <a href="#rid46">
          46
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Craniostosis resulting in a foreshortened posterior fossa [
         <a href="#rid47">
          47
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Brainstem infarction [
         <a href="#rid48">
          48,49
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pilocytic astrocytoma expanding to the trigeminal root entry zone [
         <a href="#rid50">
          50
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vascular loops compressing the trigeminal nerve [
         <a href="#rid15">
          15,51
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Parietal and parieto-occipital space occupying lesions [
         <a href="#rid15">
          15
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pathologic white matter lesions associated with multiple sclerosis [
         <a href="#rid52">
          52
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vertebral artery dissection [
         <a href="#rid53">
          53
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neuromyelitis optica spectrum disorder with a lesion in dorsolateral medulla [
         <a href="#rid54">
          54
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cerebellopontine angle meningioma [
         <a href="#rid55">
          55
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h3">
          Pituitary lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         SUNCT has been described in patients both with microadenomas [
         <a href="#rid15">
          15,56,57
         </a>
         ] and macroadenomas [
         <a href="#rid15">
          15,57-59
         </a>
         ], with attacks occurring on the side ipsilateral to the side of the tumor. In most cases, the pituitary adenomas associated with SUNCT have been prolactin or growth hormone secreting tumors. In addition, another patient with a pituitary macroadenoma had symptoms of SUNCT that were labeled as trigeminal neuralgia [
         <a href="#rid60">
          60
         </a>
         ]. Headache symptoms can precede pituitary symptoms by 3 to 10 years [
         <a href="#rid58">
          58,60
         </a>
         ].
        </p>
        <p>
         The ipsilateral localization of headache suggests a role for a direct mode of action in pituitary macroadenomas, but this mechanism would not account satisfactorily for microadenomas. An alternative hypothesis is that the attacks are mediated predominantly by a neurohormonal mechanism rather than by the size or invasiveness of the tumor [
         <a href="#rid59">
          59,61
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18716521">
         <span class="h3">
          Trigeminal neurovascular loop
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neurovascular contact with morphological changes may be an underlying cause of some cases of SUNCT and SUNA. In a cohort of 80 patients with SUNCT and 79 with SUNA, the rate of neurovascular contact with the trigeminal nerve was higher on the symptomatic side (80 versus 57 percent) [
         <a href="#rid31">
          31
         </a>
         ]. Neurovascular contact with morphological changes were also more prevalent on the symptomatic side (61 versus 31 percent).
        </p>
        <p>
         These findings raise the possibility that peripheral mechanisms play a key role in the pathophysiology of SUNCT [
         <a href="#rid62">
          62
         </a>
         ]. Some patients with SUNCT or SUNA may benefit from trigeminal microvascular decompression, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3338.html" rel="external">
          "Short-lasting unilateral neuralgiform headache attacks: Treatment and prognosis", section on 'Trigeminal nerve decompression'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2353370572">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110285.html" rel="external">
          "Society guideline links: Migraine and other primary headache disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Classification
         </strong>
         – The trigeminal autonomic cephalalgias are a group of primary headache disorders characterized by unilateral trigeminal distribution pain that occurs in association with ipsilateral cranial autonomic features. The disorders included in this category are cluster headache, paroxysmal hemicrania, hemicrania continua, and short-lasting unilateral neuralgiform headache attacks. (See
         <a class="local">
          'Introduction and classification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         There are two subtypes of short-lasting unilateral neuralgiform headache attacks (see
         <a class="local">
          'Introduction and classification'
         </a>
         above and
         <a class="local">
          'Historical aspects'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Both SUNCT and SUNA are rare headache syndromes, but the prevalence and incidence are uncertain. The typical age of onset is between 30 and 60 years but may range from 5 to 88 years. The female-to-male ratio in SUNCT and SUNA is 1.7:1. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – SUNCT and SUNA are characterized by sudden brief attacks of severe unilateral pain commonly located in ophthalmic (V1) and maxillary (V2) divisions of the trigeminal nerve and accompanied by ipsilateral cranial autonomic symptoms. In SUNCT, the ipsilateral autonomic symptoms consist of both conjunctival injection and lacrimation. In SUNA, the autonomic symptoms may include either conjunctival injection or lacrimation but not both, and there can be other cranial autonomic symptoms (eg, nasal congestion and/or rhinorrhea, eyelid edema). (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Attack patterns
         </strong>
         – In patients with SUNCT or SUNA, attacks can take one or more of four forms (
         <a class="graphic graphic_figure graphicRef74409" href="/z/d/graphic/74409.html" rel="external">
          figure 1
         </a>
         ) (see
         <a class="local">
          'Clinical features'
         </a>
         above and
         <a class="local">
          'Temporal profile of individual attacks'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Single stabs of pain
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Repetitive stabs
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A saw-tooth pattern of continuous pain with multiple superimposed stabs (serrated attacks)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Plateau-type attacks
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis and evaluation
         </strong>
         – The diagnosis of SUNCT or SUNA is based upon a compatible clinical history, typically in the setting of a normal neurologic examination, and fulfillment of diagnostic criteria (
         <a class="graphic graphic_table graphicRef74387" href="/z/d/graphic/74387.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Diagnosis'
         </a>
         above and
         <a class="local">
          'Diagnostic criteria'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For the initial evaluation of patients with SUNCT and SUNA symptoms, we suggest brain magnetic resonance imaging for patients with a normal or abnormal neurologic exam because of the possibility of underlying or alternative diagnoses. Imaging should include sequences to assess the posterior fossa and pituitary structures. (See
         <a class="local">
          'Neuroimaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The diagnosis of SUNCT or SUNA is supported by lack of response to
         <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">
          indomethacin
         </a>
         and oxygen and a good response to
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         . (See
         <a class="local">
          'Response to treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis for SUNCT and SUNA includes cluster headache, paroxysmal hemicrania, hemicrania continua, trigeminal neuralgia, and secondary causes of headache. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 1997; 120 ( Pt 1):193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goadsby PJ. Trigeminal autonomic cephalalgias. Pathophysiology and classification. Rev Neurol (Paris) 2005; 161:692.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38:1.
          </a>
         </li>
         <li class="breakAll">
          International Headache Classification of Headache Disorders, 3rd edition ichd-3.org.
         </li>
         <li class="breakAll">
          Sjaastad O, Russell D, Horven I, Bunnaes U. Multiple neuralgiform unilateral headache attacks associated with conjunctival injection and appearing in clusters. A nosological problem. Proceedings of the Scandinavian Migraine Society. Arhus, Denmark 1978. p.31.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pareja JA, Sjaastad O. SUNCT syndrome. A clinical review. Headache 1997; 37:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sjaastad O, Saunte C, Salvesen R, et al. Shortlasting unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea. Cephalalgia 1989; 9:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams MH, Broadley SA. SUNCT and SUNA: clinical features and medical treatment. J Clin Neurosci 2008; 15:526.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sjaastad O, Bakketeig LS. Cluster headache prevalence. Vågå study of headache epidemiology. Cephalalgia 2003; 23:528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sékhara T, Pelc K, Mewasingh LD, et al. Pediatric SUNCT Syndrome. Pediatr Neurol 2005; 33:206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vikelis M, Xifaras M, Mitsikostas DD. SUNCT syndrome in the elderly. Cephalalgia 2005; 25:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambru G, Rantell K, Levy A, Matharu MS. A prospective comparative study and analysis of predictors of SUNA and SUNCT. Neurology 2019; 93:e1127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gantenbein AR, Goadsby PJ. Familial SUNCT. Cephalalgia 2005; 25:457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA. Brain 2006; 129:2746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Favoni V, Grimaldi D, Pierangeli G, et al. SUNCT/SUNA and neurovascular compression: new cases and critical literature review. Cephalalgia 2013; 33:1337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weng HY, Cohen AS, Schankin C, Goadsby PJ. Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial. Cephalalgia 2018; 38:1554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matharu MS, Cohen AS, Boes CJ, Goadsby PJ. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review. Curr Pain Headache Rep 2003; 7:308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen AS, Gantenbein AR, Goadsby PJ. Abnormal blink reflex studies in a patient with supraorbital neuralgia. Cephalalgia 2006; 26:875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calvo JF, Bruera OC, de Lourdes Figuerola M, et al. SUNCT syndrome: clinical and 12-year follow-up case report. Cephalalgia 2004; 24:900.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matharu MS, Goadsby PJ. Trigeminal autonomic cephalgias. J Neurol Neurosurg Psychiatry 2002; 72 Suppl 2:ii19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graff-Radford SB. SUNCT syndrome responsive to gabapentin (Neurontin). Cephalalgia 2000; 20:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sabatowski R, Huber M, Meuser T, Radbruch L. SUNCT syndrome: a treatment option with local opioid blockade of the superior cervical ganglion? A case report. Cephalalgia 2001; 21:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raimondi E, Gardella L. SUNCT syndrome. Two cases in Argentina. Headache 1998; 38:369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Putzki N, Nirkko A, Diener HC. Trigeminal autonomic cephalalgias: a case of post-traumatic SUNCT syndrome? Cephalalgia 2005; 25:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prakash KM, Lo YL. SUNCT syndrome in association with persistent Horner syndrome in a Chinese patient. Headache 2004; 44:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen AS. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing. Cephalalgia 2007; 27:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matharu MS, Cohen AS, Frackowiak RS, Goadsby PJ. Posterior hypothalamic activation in paroxysmal hemicrania. Ann Neurol 2006; 59:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matharu MS, Cohen AS, McGonigle DJ, et al. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache 2004; 44:747.
          </a>
         </li>
         <li class="breakAll">
          Lance JW, Goadsby PJ. Mechanism and Management of Headache, 7th ed, Elsevier, New York 2005.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambru G, Rantell K, O'Connor E, et al. Trigeminal neurovascular contact in SUNCT and SUNA: a cross-sectional magnetic resonance study. Brain 2020; 143:3619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maarbjerg S, Wolfram F, Gozalov A, et al. Significance of neurovascular contact in classical trigeminal neuralgia. Brain 2015; 138:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambru G, Lagrata S, Levy A, et al. Trigeminal microvascular decompression for short-lasting unilateral neuralgiform headache attacks. Brain 2022; 145:2882.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goadsby PJ, Matharu MS, Boes CJ. SUNCT syndrome or trigeminal neuralgia with lacrimation. Cephalalgia 2001; 21:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sjaastad O, Pareja JA, Zukerman E, et al. Trigeminal neuralgia. Clinical manifestations of first division involvement. Headache 1997; 37:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambru G, Matharu MS. SUNCT, SUNA and trigeminal neuralgia: different disorders or variants of the same disorder? Curr Opin Neurol 2014; 27:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambru G, Stubberud A, Rantell K, et al. Medical treatment of SUNCT and SUNA: a prospective open-label study including single-arm meta-analysis. J Neurol Neurosurg Psychiatry 2021; 92:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ito Y, Yamamoto T, Ninomiya M, et al. Secondary SUNCT syndrome caused by viral meningitis. J Neurol 2009; 256:667.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eguia P, Garcia-Monco JC, Ruiz-Lavilla N, et al. SUNCT and trigeminal neuralgia attributed to meningoencephalitis. J Headache Pain 2008; 9:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacob S, Saha A, Rajabally Y. Post-traumatic short-lasting unilateral headache with cranial autonomic symptoms (SUNA). Cephalalgia 2008; 28:991.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Black D, Swanson J, Eross E, Cutrer FM. Secondary SUNCT due to intraorbital, metastatic bronchial carcinoid. Cephalalgia 2005; 25:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trucco M, Mainardi F, Maggioni F, et al. Chronic paroxysmal hemicrania, hemicrania continua and SUNCT syndrome in association with other pathologies: a review. Cephalalgia 2004; 24:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bussone G, Leone M, Dalla Volta G, et al. Short-lasting unilateral neuralgiform headache attacks with tearing and conjunctival injection: the first "symptomatic" case? Cephalalgia 1991; 11:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morales F, Mostacero E, Marta J, Sanchez S. Vascular malformation of the cerebellopontine angle associated with "SUNCT" syndrome. Cephalalgia 1994; 14:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Benedittis G. SUNCT syndrome associated with cavernous angioma of the brain stem. Cephalalgia 1996; 16:503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ter Berg JW, Goadsby PJ. Significance of atypical presentation of symptomatic SUNCT: a case report. J Neurol Neurosurg Psychiatry 2001; 70:244.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morís G, Ribacoba R, Solar DN, Vidal JA. SUNCT syndrome and seborrheic dermatitis associated with craneosynostosis. Cephalalgia 2001; 21:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Penart A, Firth M, Bowen JR. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) following presumed dorsolateral brainstem infarction. Cephalalgia 2001; 21:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambru G, Trimboli M, Tan SV, Al-Kaisy A. Medullary infarction causing coexistent SUNCT and trigeminal neuralgia. Cephalalgia 2017; 37:486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blättler T, Capone Mori A, Boltshauser E, Bassetti C. Symptomatic SUNCT in an eleven-year-old girl. Neurology 2003; 60:2012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Köseoglu E, Karaman Y, Kücük S, Arman F. SUNCT syndrome associated with compression of trigeminal nerve. Cephalalgia 2005; 25:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vilisaar J, Constantinescu CS. SUNCT in multiple sclerosis. Cephalalgia 2006; 26:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacob S, Rajabally Y. Short-lasting unilateral neuralgiform headache with cranial autonomic symptoms (SUNA) following vertebral artery dissection. Cephalalgia 2007; 27:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cao Y, Yang F, Dong Z, et al. Secondary Short-Lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing: A New Case and a Literature Review. J Clin Neurol 2018; 14:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Talavera B, Guerrero ÁL, García-Azorín D. SUNCT Headache Occurring Secondary to a Cerebellopontine Angle Meningioma Reinforces the Hypothesis of Trigeminal Nerve Compression. Pain Med 2021; 22:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy MJ, Matharu MS, Goadsby PJ. Prolactinomas, dopamine agonists and headache: two case reports. Eur J Neurol 2003; 10:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chitsantikul P, Becker WJ. SUNCT, SUNA and pituitary tumors: clinical characteristics and treatment. Cephalalgia 2013; 33:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Massiou H, Launay JM, Levy C, et al. SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks. Neurology 2002; 58:1698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matharu MS, Levy MJ, Merry RT, Goadsby PJ. SUNCT syndrome secondary to prolactinoma. J Neurol Neurosurg Psychiatry 2003; 74:1590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferrari MD, Haan J, van Seters AP. Bromocriptine-induced trigeminal neuralgia attacks in a patient with a pituitary tumor. Neurology 1988; 38:1482.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy MJ, Jäger HR, Powell M, et al. Pituitary volume and headache: size is not everything. Arch Neurol 2004; 61:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irimia P, González-Redondo R, Domínguez PD, et al. Microvascular decompression may be effective for refractory SUNCT regardless of symptom duration. Cephalalgia 2010; 30:626.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3336 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9055807" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16141962" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Trigeminal autonomic cephalalgias. Pathophysiology and classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29368949" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29368949" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29368949" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9150613" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : SUNCT syndrome. A clinical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2743414" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Shortlasting unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14979299" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The International Classification of Headache Disorders: 2nd edition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18325769" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : SUNCT and SUNA: clinical features and medical treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12950378" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Cluster headache prevalence. Vågåstudy of headache epidemiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16139736" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Pediatric SUNCT Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16232162" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : SUNCT syndrome in the elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31427501" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : A prospective comparative study and analysis of predictors of SUNA and SUNCT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15910571" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Familial SUNCT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16905753" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23800827" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : SUNCT/SUNA and neurovascular compression: new cases and critical literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29096522" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12828881" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16776705" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Abnormal blink reflex studies in a patient with supraorbital neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15377323" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : SUNCT syndrome: clinical and 12-year follow-up case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12122199" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Trigeminal autonomic cephalgias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11037748" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : SUNCT syndrome responsive to gabapentin (Neurontin).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11422100" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : SUNCT syndrome: a treatment option with local opioid blockade of the superior cervical ganglion? A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9630790" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : SUNCT syndrome. Two cases in Argentina.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15839855" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Trigeminal autonomic cephalalgias: a case of post-traumatic SUNCT syndrome?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15012664" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : SUNCT syndrome in association with persistent Horner syndrome in a Chinese patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17598764" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16489610" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Posterior hypothalamic activation in paroxysmal hemicrania.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15330820" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Posterior hypothalamic and brainstem activation in hemicrania continua.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15330820" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Posterior hypothalamic and brainstem activation in hemicrania continua.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33301567" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Trigeminal neurovascular contact in SUNCT and SUNA: a cross-sectional magnetic resonance study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25541189" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Significance of neurovascular contact in classical trigeminal neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35325067" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Trigeminal microvascular decompression for short-lasting unilateral neuralgiform headache attacks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11422087" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : SUNCT syndrome or trigeminal neuralgia with lacrimation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9237408" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Trigeminal neuralgia. Clinical manifestations of first division involvement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24792341" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : SUNCT, SUNA and trigeminal neuralgia: different disorders or variants of the same disorder?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33361408" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Medical treatment of SUNCT and SUNA: a prospective open-label study including single-arm meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19444540" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Secondary SUNCT syndrome caused by viral meningitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18217200" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : SUNCT and trigeminal neuralgia attributed to meningoencephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18513261" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Post-traumatic short-lasting unilateral headache with cranial autonomic symptoms (SUNA).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16033391" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Secondary SUNCT due to intraorbital, metastatic bronchial carcinoid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15009010" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Chronic paroxysmal hemicrania, hemicrania continua and SUNCT syndrome in association with other pathologies: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1889067" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Short-lasting unilateral neuralgiform headache attacks with tearing and conjunctival injection: the first "symptomatic" case?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7954761" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Vascular malformation of the cerebellopontine angle associated with "SUNCT" syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8933996" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : SUNCT syndrome associated with cavernous angioma of the brain stem.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11160478" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Significance of atypical presentation of symptomatic SUNCT: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11422101" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : SUNCT syndrome and seborrheic dermatitis associated with craneosynostosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11442560" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) following presumed dorsolateral brainstem infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27226002" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Medullary infarction causing coexistent SUNCT and trigeminal neuralgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12821758" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Symptomatic SUNCT in an eleven-year-old girl.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15910575" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : SUNCT syndrome associated with compression of trigeminal nerve.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16776709" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : SUNCT in multiple sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17381562" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Short-lasting unilateral neuralgiform headache with cranial autonomic symptoms (SUNA) following vertebral artery dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29856156" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Secondary Short-Lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing: A New Case and a Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32330271" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : SUNCT Headache Occurring Secondary to a Cerebellopontine Angle Meningioma Reinforces the Hypothesis of Trigeminal Nerve Compression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12603293" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Prolactinomas, dopamine agonists and headache: two case reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23197348" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : SUNCT, SUNA and pituitary tumors: clinical characteristics and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12058109" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14617728" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : SUNCT syndrome secondary to prolactinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3412598" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Bromocriptine-induced trigeminal neuralgia attacks in a patient with a pituitary tumor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15148150" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Pituitary volume and headache: size is not everything.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19614700" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Microvascular decompression may be effective for refractory SUNCT regardless of symptom duration.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
